A detailed history of Sofinnova Investments, Inc. transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 85,640 shares of ATXS stock, worth $806,728. This represents 0.09% of its overall portfolio holdings.

Number of Shares
85,640
Previous 60,692 41.11%
Holding current value
$806,728
Previous $552,000 70.65%
% of portfolio
0.09%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.97 - $12.65 $223,783 - $315,592
24,948 Added 41.11%
85,640 $942,000
Q2 2024

Aug 09, 2024

BUY
$8.83 - $13.51 $535,910 - $819,948
60,692 New
60,692 $552,000

Others Institutions Holding ATXS

About Astria Therapeutics, Inc.


  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $143M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.